Financial reports
10-Q
2024 Q1
Quarterly report
7 May 24
ARS
2023 FY
Annual report to shareholders
26 Apr 24
10-K
2023 FY
Annual report
29 Feb 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
14 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
Current reports
8-K
Submission of Matters to a Vote of Security Holders
11 Jun 24
8-K
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
7 May 24
8-K
Departure of Directors or Certain Officers
9 Apr 24
8-K
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
5 Apr 24
8-K
Departure of Directors or Certain Officers
2 Apr 24
8-K
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
14 Feb 24
8-K
Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update
9 Nov 23
8-K
Departure of Directors or Certain Officers
1 Sep 23
8-K
Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results
2 Aug 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3 Jul 23
Registration and prospectus
S-8
Registration of securities for employees
14 Feb 23
424B7
Prospectus with selling stockholder info
21 Aug 20
424B5
Prospectus supplement for primary offering
16 Jul 20
424B5
Prospectus supplement for primary offering
14 Jul 20
S-3ASR
Automatic shelf registration
14 Jul 20
424B4
Prospectus supplement with pricing info
24 Jan 20
S-1/A
IPO registration (amended)
22 Jan 20
S-1
IPO registration
21 Jan 20
DRS
Draft registration statement
9 Jan 20
S-8
Registration of securities for employees
1 Jul 19
Proxies
DEFA14A
Additional proxy soliciting materials
24 May 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
DEFA14A
Additional proxy soliciting materials
1 Jun 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
22 Apr 22
DEF 14A
Definitive proxy
22 Apr 22
DEFA14A
Additional proxy soliciting materials
23 Apr 21
DEF 14A
Definitive proxy
23 Apr 21
Other
EFFECT
Notice of effectiveness
24 Jan 20
CORRESP
Correspondence with SEC
21 Jan 20
CORRESP
Correspondence with SEC
21 Jan 20
UPLOAD
Letter from SEC
15 Jan 20
EFFECT
Notice of effectiveness
27 Jun 19
CERT
Certification of approval for exchange listing
26 Jun 19
CORRESP
Correspondence with SEC
24 Jun 19
CORRESP
Correspondence with SEC
24 Jun 19
SEC STAFF
SEC staff action: Order
19 Jun 19
CORRESP
Correspondence with SEC
17 Jun 19
Ownership
SC 13G
INTEGRATED CORE STRATEGIES (US) LLC
28 May 24
4
KYLE PISKEL
17 May 24
4
PETER M NEUPERT
13 Mar 24
4
Michael J Pellini
6 Mar 24
4
KATEY EINTERZ OWEN
6 Mar 24
4
PETER M NEUPERT
6 Mar 24
4
ROBERT HERSHBERG
6 Mar 24
4
MICHELLE RENEE GRIFFIN
6 Mar 24
4
KYLE PISKEL
6 Mar 24
4
Stacy L Taylor
6 Mar 24